四种制剂中地高辛生物利用度的差异。 - Suppr

Suppr

超能文献

Variation in biologic availability of digoxin from four preparations.

作者信息

Lindenbaum J, Mellow M H, Blackstone M O, Butler V P

出版信息

N Engl J Med. 1971 Dec 9;285(24):1344-7. doi: 10.1056/NEJM197112092852403.

DOI:10.1056/NEJM197112092852403

PMID:5121186

Abstract

摘要

相似文献

Variation in biologic availability of digoxin from four preparations.

N Engl J Med. 1971 Dec 9;285(24):1344-7. doi: 10.1056/NEJM197112092852403.

Dissimilarities of digoxin.

N Engl J Med. 1971 Dec 9;285(24):1376-7. doi: 10.1056/NEJM197112092852414.

Non-equivalence of digoxin tablets.

Ann Clin Res. 1974;6(0):suppl 11:4-8.

Digoxin preparations: variation in biological availability.

Med J Aust. 1973 Nov 17;2(20):922-5.

Bioavailability of digoxin from tablets. III. Availability of digoxin in man from preparations with different dissolution rate.

Acta Pharm Suec. 1974 Nov;11(5):471-92.

Variation in the biological availability of digoxin.

Lancet. 1972 Aug 12;2(7772):303-7. doi: 10.1016/s0140-6736(72)92908-x.

Evaluation of digoxin bioavailability in single-dose studies.

N Engl J Med. 1973 Sep 27;289(13):651-4. doi: 10.1056/NEJM197309272891302.

[Absorption of digoxin following oral administration. A comparison of different preparations].

Ugeskr Laeger. 1974 Mar 18;136(12):640-3.

Serum-digoxin concentrations with a new digoxin derivative, beta-methyl-digoxin.

Ann Clin Res. 1973 Apr;5(2):87-90.

Biological availability of digoxin from Lanoxin produced in the United Kingdom.

Br Med J. 1973 Nov 10;4(5888):323-6. doi: 10.1136/bmj.4.5888.323.

引用本文的文献

Methods to Study Colon Release: State of the Art and An Outlook on New Strategies for Better Biorelevant Release Media.

Pharmaceutics. 2019 Feb 22;11(2):95. doi: 10.3390/pharmaceutics11020095.

Synergic development of pharmacokinetics and bioanalytical methods as support of pharmaceutical research.

Int J Immunopathol Pharmacol. 2016 Jun;29(2):168-79. doi: 10.1177/0394632015589531. Epub 2015 Dec 18.

Bioequivalence and Bioavailability Clinical Trials: A Status Report from the National Institutes of Health ClinicalTrials.gov Registry.

J Bioequivalence Bioavailab. 2013 Nov 4;5:244-247. doi: 10.4172/jbb.1000167.

Bioavailability of different preparations of paracetamol.

Br J Clin Pharmacol. 1974 Dec;1(6):495-8. doi: 10.1111/j.1365-2125.1974.tb01700.x.

Bioavailability of digoxin from rapidly dissolving preparations.

Br J Clin Pharmacol. 1974 Aug;1(4):329-33. doi: 10.1111/j.1365-2125.1974.tb00262.x.

Quantitative clinical pharmacology is transforming drug regulation.

J Pharmacokinet Pharmacodyn. 2010 Dec;37(6):617-28. doi: 10.1007/s10928-010-9171-3. Epub 2010 Oct 27.

Bioequivalence: tried and tested.

Cardiovasc J Afr. 2010 Mar-Apr;21(2):69-71.

A history of biopharmaceutics in the Food and Drug Administration 1968-1993.

AAPS J. 2010 Mar;12(1):44-50. doi: 10.1208/s12248-009-9154-8. Epub 2009 Nov 20.

Pharmacokinetics of digoxin cross-reacting substances in patients with acute yellow Oleander (Thevetia peruviana) poisoning, including the effect of activated charcoal.

Ther Drug Monit. 2006 Dec;28(6):784-92. doi: 10.1097/FTD.0b013e31802bfd69.

Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans.

Health Serv Res. 2003 Aug;38(4):1051-63. doi: 10.1111/1475-6773.00162.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验